speb/financial-data huggingface dataset:
CHR income_statement (annual, 2025-12-31) — +Total Revenue: 148835000.00
CHR balance_sheet (annual, 2025-12-31) — Accounts Payable: 2744000.00
CHR balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 2744000.00
CHR balance_sheet (annual, 2025-12-31) — Accounts Receivable: 79681000.00
CHR balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 79681000.00
CHR balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -812000.00
CHR balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -812000.00
CHR balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 137734000.00
CHR balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 137734000.00
CHR balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CHR balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: 0.00
CHR cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 1210000.00
CHR income_statement (annual, 2025-12-31) — Basic Average Shares: 1064433.00
CHR income_statement (annual, 2025-12-31) — Basic EPS: 24.07
CHR cash_flow (annual, 2025-12-31) — Beginning Cash Position: 197660000.00
CHR balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 261000.00
CHR balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 261000.00
CHR cash_flow (annual, 2025-12-31) — Capital Expenditure: -709000.00
CHR balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 261000.00
CHR balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 261000.00
CHR balance_sheet (annual, 2025-12-31) — Capital Stock: 234000.00
CHR balance_sheet (quarterly, 2025-12-31) — Capital Stock: 234000.00
CHR balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 242082000.00
CHR balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 242082000.00
CHR balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 242082000.00
CHR balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 242082000.00
CHR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 17824000.00
CHR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -709000.00
CHR cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 17939000.00
CHR cash_flow (annual, 2025-12-31) — Change In Account Payable: 599000.00
CHR cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -1497000.00
CHR cash_flow (annual, 2025-12-31) — Change In Income Tax Payable: -6722000.00
CHR cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 0.00
CHR cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -111000.00
CHR cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -26000.00
CHR cash_flow (annual, 2025-12-31) — Change In Payable: -6123000.00
CHR cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -7620000.00
CHR cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -10218000.00
CHR cash_flow (annual, 2025-12-31) — Change In Receivables: 1538000.00
CHR cash_flow (annual, 2025-12-31) — Change In Tax Payable: -6722000.00
CHR cash_flow (annual, 2025-12-31) — Change In Working Capital: -16437000.00
CHR cash_flow (annual, 2025-12-31) — Changes In Account Receivables: 1538000.00
CHR cash_flow (annual, 2025-12-31) — Changes In Cash: 35054000.00
CHR balance_sheet (annual, 2025-12-31) — Common Stock: 234000.00
CHR balance_sheet (quarterly, 2025-12-31) — Common Stock: 234000.00
CHR balance_sheet (annual, 2025-12-31) — Common Stock Equity: 369683000.00
CHR balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 369683000.00
CHR cash_flow (annual, 2025-12-31) — Common Stock Issuance: 21044000.00
CHR income_statement (annual, 2025-12-31) — Cost Of Revenue: 43209000.00
CHR balance_sheet (annual, 2025-12-31) — Current Assets: 366585000.00
CHR balance_sheet (quarterly, 2025-12-31) — Current Assets: 366585000.00
CHR balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 127000.00
CHR balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 127000.00
CHR balance_sheet (annual, 2025-12-31) — Current Debt: 6435000.00
CHR balance_sheet (quarterly, 2025-12-31) — Current Debt: 6435000.00
CHR balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6562000.00
CHR balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6562000.00
CHR balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1000.00
CHR balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1000.00
CHR balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1000.00
CHR balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1000.00
CHR balance_sheet (annual, 2025-12-31) — Current Liabilities: 31789000.00
CHR balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 31789000.00
CHR cash_flow (annual, 2025-12-31) — Deferred Income Tax: 73000.00
CHR cash_flow (annual, 2025-12-31) — Deferred Tax: 73000.00
CHR cash_flow (annual, 2025-12-31) — Depreciation: 7004000.00
CHR cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 7004000.00
CHR cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 7004000.00
CHR income_statement (annual, 2025-12-31) — Diluted Average Shares: 1064433.00
CHR income_statement (annual, 2025-12-31) — Diluted EPS: 24.07
CHR income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 25617000.00
CHR balance_sheet (annual, 2025-12-31) — Dueto Related Parties Current: 2753000.00
CHR balance_sheet (quarterly, 2025-12-31) — Dueto Related Parties Current: 2753000.00
CHR income_statement (annual, 2025-12-31) — EBIT: 26288000.00
CHR income_statement (annual, 2025-12-31) — EBITDA: 33292000.00
CHR cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 9368000.00
CHR cash_flow (annual, 2025-12-31) — End Cash Position: 242082000.00
CHR cash_flow (annual, 2025-12-31) — Financing Cash Flow: 17824000.00
CHR cash_flow (annual, 2025-12-31) — Free Cash Flow: 17230000.00
CHR balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1030000.00
CHR balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -1030000.00
CHR income_statement (annual, 2025-12-31) — General And Administrative Expense: 4724000.00
CHR balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 34734000.00
CHR balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 34734000.00
CHR balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 79681000.00
CHR balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 79681000.00
CHR balance_sheet (annual, 2025-12-31) — Gross PPE: 1090000.00
CHR balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1090000.00
CHR income_statement (annual, 2025-12-31) — Gross Profit: 105626000.00
CHR cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
CHR balance_sheet (annual, 2025-12-31) — Income Tax Payable: 2495000.00
CHR balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 2495000.00
CHR cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 366000.00
CHR balance_sheet (annual, 2025-12-31) — Invested Capital: 376118000.00
CHR balance_sheet (quarterly, 2025-12-31) — Invested Capital: 376118000.00
CHR cash_flow (annual, 2025-12-31) — Investing Cash Flow: -709000.00
CHR cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 21044000.00
CHR cash_flow (annual, 2025-12-31) — Issuance Of Debt: 9302000.00
CHR balance_sheet (annual, 2025-12-31) — Leases: 185000.00
CHR balance_sheet (quarterly, 2025-12-31) — Leases: 185000.00
CHR balance_sheet (annual, 2025-12-31) — Line Of Credit: 6435000.00
CHR balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 6435000.00
CHR balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 134000.00
CHR balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 134000.00
CHR balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 134000.00
CHR balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 134000.00
CHR cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1650000.00
CHR balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 63000.00
CHR balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 63000.00
CHR balance_sheet (annual, 2025-12-31) — Minority Interest: 85000.00
CHR balance_sheet (quarterly, 2025-12-31) — Minority Interest: 85000.00
CHR income_statement (annual, 2025-12-31) — Minority Interests: -4000.00
CHR cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 21044000.00
CHR income_statement (annual, 2025-12-31) — Net Income: 25617000.00
CHR income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 25617000.00
CHR income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 25621000.00
CHR income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 25617000.00
CHR income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 25617000.00
CHR cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 25621000.00
CHR income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 25621000.00
CHR cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -709000.00
CHR income_statement (annual, 2025-12-31) — Net Interest Income: 69000.00
CHR cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -3220000.00
CHR cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 1650000.00
CHR income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 69000.00
CHR balance_sheet (annual, 2025-12-31) — Net PPE: 278000.00
CHR balance_sheet (quarterly, 2025-12-31) — Net PPE: 278000.00
CHR cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 0.00
CHR cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -4870000.00
CHR balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 334949000.00
CHR balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 334949000.00
CHR balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 0.00
CHR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 0.00
CHR balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
CHR balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 0.00
CHR income_statement (annual, 2025-12-31) — Normalized EBITDA: 33292000.00
CHR income_statement (annual, 2025-12-31) — Normalized Income: 25617000.00
CHR cash_flow (annual, 2025-12-31) — Operating Cash Flow: 17939000.00
CHR income_statement (annual, 2025-12-31) — Operating Income: 26288000.00
CHR income_statement (annual, 2025-12-31) — Operating Revenue: 148784000.00
CHR balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 1562082.00
CHR balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1562082.00
CHR balance_sheet (annual, 2025-12-31) — Other Current Assets: 4000.00
CHR balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 4000.00
CHR balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -1030000.00
CHR balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -1030000.00
CHR income_statement (annual, 2025-12-31) — Other Gand A: 4724000.00
CHR income_statement (annual, 2025-12-31) — Other Income Expense: -663000.00
CHR cash_flow (annual, 2025-12-31) — Other Non Cash Items: -22000.00
CHR balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 94000.00
CHR balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 94000.00
CHR income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -663000.00
CHR balance_sheet (annual, 2025-12-31) — Other Payable: 444000.00
CHR balance_sheet (quarterly, 2025-12-31) — Other Payable: 444000.00
CHR balance_sheet (annual, 2025-12-31) — Other Properties: 581000.00
CHR balance_sheet (quarterly, 2025-12-31) — Other Properties: 581000.00
CHR balance_sheet (annual, 2025-12-31) — Payables: 25226000.00
CHR balance_sheet (quarterly, 2025-12-31) — Payables: 25226000.00
CHR balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 25226000.00
CHR balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 25226000.00
CHR balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CHR balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CHR balance_sheet (annual, 2025-12-31) — Prepaid Assets: 44818000.00
CHR balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 44818000.00
CHR income_statement (annual, 2025-12-31) — Pretax Income: 25694000.00
CHR balance_sheet (annual, 2025-12-31) — Properties: 0.00
CHR balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CHR cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -2939000.00
CHR cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -709000.00
CHR cash_flow (annual, 2025-12-31) — Purchase Of PPE: 0.00
CHR balance_sheet (annual, 2025-12-31) — Receivables: 79681000.00
CHR balance_sheet (quarterly, 2025-12-31) — Receivables: 79681000.00
CHR balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: 0.00
CHR balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: 0.00
CHR income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 43209000.00
CHR income_statement (annual, 2025-12-31) — Reconciled Depreciation: 7004000.00
CHR cash_flow (annual, 2025-12-31) — Repayment Of Debt: -12522000.00
CHR income_statement (annual, 2025-12-31) — Research And Development: 5173000.00
CHR balance_sheet (annual, 2025-12-31) — Retained Earnings: 232745000.00
CHR balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 232745000.00
CHR income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 69441000.00
CHR income_statement (annual, 2025-12-31) — Selling General And Administration: 74165000.00
CHR balance_sheet (annual, 2025-12-31) — Share Issued: 1562082.00
CHR balance_sheet (quarterly, 2025-12-31) — Share Issued: 1562082.00
CHR cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 7652000.00
CHR cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -12522000.00
CHR cash_flow (annual, 2025-12-31) — Stock Based Compensation: 3429000.00
CHR balance_sheet (annual, 2025-12-31) — Stockholders Equity: 369683000.00
CHR balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 369683000.00
CHR balance_sheet (annual, 2025-12-31) — Tangible Book Value: 334949000.00
CHR balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 334949000.00
CHR income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHR income_statement (annual, 2025-12-31) — Tax Provision: 73000.00
CHR income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.02
CHR balance_sheet (annual, 2025-12-31) — Total Assets: 401691000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Assets: 401691000.00
CHR balance_sheet (annual, 2025-12-31) — Total Capitalization: 369683000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 369683000.00
CHR balance_sheet (annual, 2025-12-31) — Total Debt: 6696000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Debt: 6696000.00
CHR balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 369768000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 369768000.00
CHR income_statement (annual, 2025-12-31) — Total Expenses: 122547000.00
CHR balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 31923000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 31923000.00
CHR balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 35106000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 35106000.00
CHR balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 134000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 134000.00
CHR income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 26288000.00
CHR income_statement (annual, 2025-12-31) — Total Other Finance Cost: -69000.00
CHR balance_sheet (annual, 2025-12-31) — Total Tax Payable: 19285000.00
CHR balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 19285000.00
CHR balance_sheet (annual, 2025-12-31) — Working Capital: 334796000.00
CHR balance_sheet (quarterly, 2025-12-31) — Working Capital: 334796000.00
CHR.AX income_statement (annual, 2022-06-30) — +Operating Expense: 1717578.00
CHR.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 82447.00
CHR.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 65769164.00
CHR.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.03
CHR.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 79991.00
CHR.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -1308858.00
CHR.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -1297316.00
CHR.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 8720046.00
CHR.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 3467990.00
CHR.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 3467990.00
CHR.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 3467990.00
CHR.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 5709057.00
CHR.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -1308858.00
CHR.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1012200.00
CHR.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 3387999.00
CHR.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -1012960.00
CHR.AX balance_sheet (annual, 2022-06-30) — Common Stock: 8720046.00
CHR.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 7403371.00
CHR.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 6000000.00
CHR.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -290943.00
CHR.AX balance_sheet (annual, 2022-06-30) — Current Assets: 3550357.00
CHR.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 255672.00
CHR.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 1950.00
CHR.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 1950.00
CHR.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 1950.00
CHR.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 65769164.00
CHR.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.03
CHR.AX income_statement (annual, 2022-06-30) — EBIT: -1717578.00
CHR.AX income_statement (annual, 2022-06-30) — EBITDA: -1715628.00
CHR.AX cash_flow (annual, 2022-06-30) — End Cash Position: 3467990.00
CHR.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 5709057.00
CHR.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -2321058.00
CHR.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 782927.00
CHR.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 1461950.00
CHR.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 4108686.00
CHR.AX income_statement (annual, 2022-06-30) — Impairment Of Capital Assets: 2925.00
CHR.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 760.00
CHR.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 7403371.00
CHR.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -1308858.00
CHR.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 6000000.00
CHR.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 9592.00
CHR.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 5709057.00
CHR.AX income_statement (annual, 2022-06-30) — Net Income: -1719743.00
CHR.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -1719743.00
CHR.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -1719743.00
CHR.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -1719743.00
CHR.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -1719743.00
CHR.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -1719743.00
CHR.AX balance_sheet (annual, 2022-06-30) — Net PPE: 4108686.00
CHR.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -11542.00
CHR.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 7403371.00
CHR.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -1712703.00
CHR.AX income_statement (annual, 2022-06-30) — Normalized Income: -1716818.00
CHR.AX income_statement (annual, 2022-06-30) — Operating Income: -1717578.00
CHR.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 67145753.00
CHR.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 782927.00
CHR.AX income_statement (annual, 2022-06-30) — Other Gand A: 350150.00
CHR.AX income_statement (annual, 2022-06-30) — Other Income Expense: -2165.00
CHR.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 760.00
CHR.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 253678.00
CHR.AX balance_sheet (annual, 2022-06-30) — Other Payable: 173225.00
CHR.AX balance_sheet (annual, 2022-06-30) — Other Properties: 4099094.00
CHR.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 50567.00
CHR.AX balance_sheet (annual, 2022-06-30) — Payables: 255672.00
CHR.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 255672.00
CHR.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -1012960.00
CHR.AX balance_sheet (annual, 2022-06-30) — Prepaid Assets: 31800.00
CHR.AX income_statement (annual, 2022-06-30) — Pretax Income: -1719743.00
CHR.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -11542.00
CHR.AX balance_sheet (annual, 2022-06-30) — Receivables: 50567.00
CHR.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 1950.00
CHR.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -290943.00
CHR.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -2099602.00
CHR.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 1111800.00
CHR.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 1461950.00
CHR.AX balance_sheet (annual, 2022-06-30) — Share Issued: 67145753.00
CHR.AX income_statement (annual, 2022-06-30) — Special Income Charges: -2925.00
CHR.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 7403371.00
CHR.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 7403371.00
CHR.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
CHR.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
CHR.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
CHR.AX balance_sheet (annual, 2022-06-30) — Total Assets: 7659043.00
CHR.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 7403371.00
CHR.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 7403371.00
CHR.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 255672.00
CHR.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 4108686.00
CHR.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CHR.AX income_statement (annual, 2022-06-30) — Total Unusual Items: -2925.00
CHR.AX income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: -2925.00
CHR.AX balance_sheet (annual, 2022-06-30) — Working Capital: 3294685.00
CHR.AX income_statement (annual, 2023-06-30) — +Operating Expense: 1665781.00
CHR.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 456983.00
CHR.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -21741.00
CHR.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 78281215.00
CHR.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.02
CHR.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 3467990.00
CHR.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -3194973.00
CHR.AX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -3068523.00
CHR.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 13953119.00
CHR.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 4257506.00
CHR.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 4257506.00
CHR.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 4257506.00
CHR.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 5170000.00
CHR.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -3194973.00
CHR.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1185511.00
CHR.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 789516.00
CHR.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -1267631.00
CHR.AX balance_sheet (annual, 2023-06-30) — Common Stock: 13953119.00
CHR.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 11245002.00
CHR.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 5500000.00
CHR.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -330000.00
CHR.AX balance_sheet (annual, 2023-06-30) — Current Assets: 4454421.00
CHR.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 799184.00
CHR.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 3791.00
CHR.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 21005.00
CHR.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 21005.00
CHR.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 21005.00
CHR.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 78281215.00
CHR.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.02
CHR.AX income_statement (annual, 2023-06-30) — EBIT: -1665781.00
CHR.AX income_statement (annual, 2023-06-30) — EBITDA: -1644776.00
CHR.AX cash_flow (annual, 2023-06-30) — End Cash Position: 4257506.00
CHR.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 5170000.00
CHR.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -4380484.00
CHR.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 975146.00
CHR.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 1167966.00
CHR.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 7611506.00
CHR.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 82120.00
CHR.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 11245002.00
CHR.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -3194973.00
CHR.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 5500000.00
CHR.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 135138.00
CHR.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 5170000.00
CHR.AX income_statement (annual, 2023-06-30) — Net Income: -1583661.00
CHR.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -1583661.00
CHR.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -1583661.00
CHR.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -1583661.00
CHR.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -1583661.00
CHR.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -1583661.00
CHR.AX balance_sheet (annual, 2023-06-30) — Net PPE: 7589765.00
CHR.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -126450.00
CHR.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 11245002.00
CHR.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -1644776.00
CHR.AX income_statement (annual, 2023-06-30) — Normalized Income: -1583661.00
CHR.AX income_statement (annual, 2023-06-30) — Operating Income: -1665781.00
CHR.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 81809167.00
CHR.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 975146.00
CHR.AX income_statement (annual, 2023-06-30) — Other Gand A: 660969.00
CHR.AX income_statement (annual, 2023-06-30) — Other Income Expense: 82120.00
CHR.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 82120.00
CHR.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 476810.00
CHR.AX balance_sheet (annual, 2023-06-30) — Other Payable: 338410.00
CHR.AX balance_sheet (annual, 2023-06-30) — Other Properties: 7476368.00
CHR.AX balance_sheet (annual, 2023-06-30) — Other Receivables: 116665.00
CHR.AX balance_sheet (annual, 2023-06-30) — Payables: 795393.00
CHR.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 795393.00
CHR.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -1267631.00
CHR.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 80250.00
CHR.AX income_statement (annual, 2023-06-30) — Pretax Income: -1583661.00
CHR.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -126450.00
CHR.AX balance_sheet (annual, 2023-06-30) — Receivables: 116665.00
CHR.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 21005.00
CHR.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -330000.00
CHR.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -3683263.00
CHR.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 506997.00
CHR.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1167966.00
CHR.AX balance_sheet (annual, 2023-06-30) — Share Issued: 81809167.00
CHR.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 11245002.00
CHR.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 11245002.00
CHR.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
CHR.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
CHR.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
CHR.AX balance_sheet (annual, 2023-06-30) — Total Assets: 12044186.00
CHR.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 11245002.00
CHR.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 11245002.00
CHR.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 799184.00
CHR.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 7589765.00
CHR.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
CHR.AX balance_sheet (annual, 2023-06-30) — Working Capital: 3655237.00
CHR.AX income_statement (annual, 2024-06-30) — +Operating Expense: 2150438.00
CHR.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 230136.00
CHR.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -73993.00
CHR.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 92906070.00
CHR.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.03
CHR.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 4257506.00
CHR.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -5977366.00
CHR.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -3932480.00
CHR.AX balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 89404.00
CHR.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 17629821.00
CHR.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 3301018.00
CHR.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 3301018.00
CHR.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 3301018.00
CHR.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 3664565.00
CHR.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -3371628.00
CHR.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1249425.00
CHR.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -956488.00
CHR.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -1285142.00
CHR.AX balance_sheet (annual, 2024-06-30) — Common Stock: 17629821.00
CHR.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 13255850.00
CHR.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 2703000.00
CHR.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -169680.00
CHR.AX balance_sheet (annual, 2024-06-30) — Current Assets: 3343407.00
CHR.AX balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 41976.00
CHR.AX balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 41976.00
CHR.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 437114.00
CHR.AX balance_sheet (annual, 2024-06-30) — Current Provisions: 26317.00
CHR.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 84501.00
CHR.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 84501.00
CHR.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 84501.00
CHR.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 92906070.00
CHR.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.03
CHR.AX income_statement (annual, 2024-06-30) — EBIT: -2374585.00
CHR.AX income_statement (annual, 2024-06-30) — EBITDA: -2290084.00
CHR.AX cash_flow (annual, 2024-06-30) — End Cash Position: 3301018.00
CHR.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 3664565.00
CHR.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -7226791.00
CHR.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 1689103.00
CHR.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 1746086.00
CHR.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 10470978.00
CHR.AX income_statement (annual, 2024-06-30) — Impairment Of Capital Assets: 279940.00
CHR.AX income_statement (annual, 2024-06-30) — Interest Expense: 5226.00
CHR.AX income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 5226.00
CHR.AX income_statement (annual, 2024-06-30) — Interest Income: 35717.00
CHR.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 35717.00
CHR.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 35717.00
CHR.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 13255850.00
CHR.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -3371628.00
CHR.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 2703000.00
CHR.AX cash_flow (annual, 2024-06-30) — Issuance Of Debt: 1200000.00
CHR.AX balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 47428.00
CHR.AX balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 47428.00
CHR.AX cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 1200000.00
CHR.AX cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -68755.00
CHR.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 94851.00
CHR.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 2533320.00
CHR.AX income_statement (annual, 2024-06-30) — Net Income: -2379811.00
CHR.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -2379811.00
CHR.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -2379811.00
CHR.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -2379811.00
CHR.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -2379811.00
CHR.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -2379811.00
CHR.AX income_statement (annual, 2024-06-30) — Net Interest Income: 30491.00
CHR.AX cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: 1131245.00
CHR.AX cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: 1131245.00
CHR.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 30491.00
CHR.AX cash_flow (annual, 2024-06-30) — Net Other Investing Changes: 2540738.00
CHR.AX balance_sheet (annual, 2024-06-30) — Net PPE: 10396985.00
CHR.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -1979886.00
CHR.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 13255850.00
CHR.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -2010144.00
CHR.AX income_statement (annual, 2024-06-30) — Normalized Income: -2099871.00
CHR.AX income_statement (annual, 2024-06-30) — Operating Income: -2150438.00
CHR.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 101968134.00
CHR.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 1689103.00
CHR.AX income_statement (annual, 2024-06-30) — Other Gand A: 619859.00
CHR.AX income_statement (annual, 2024-06-30) — Other Income Expense: -259864.00
CHR.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: 20076.00
CHR.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 599791.00
CHR.AX balance_sheet (annual, 2024-06-30) — Other Payable: 138685.00
CHR.AX balance_sheet (annual, 2024-06-30) — Other Properties: 10376127.00
CHR.AX balance_sheet (annual, 2024-06-30) — Payables: 368821.00
CHR.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 368821.00
CHR.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -1285142.00
CHR.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 42389.00
CHR.AX income_statement (annual, 2024-06-30) — Pretax Income: -2379811.00
CHR.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -2044886.00
CHR.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 84501.00
CHR.AX cash_flow (annual, 2024-06-30) — Repayment Of Debt: -68755.00
CHR.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -169680.00
CHR.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -6063074.00
CHR.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 1126227.00
CHR.AX cash_flow (annual, 2024-06-30) — Sale Of PPE: 65000.00
CHR.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1746086.00
CHR.AX balance_sheet (annual, 2024-06-30) — Share Issued: 101968134.00
CHR.AX income_statement (annual, 2024-06-30) — Special Income Charges: -279940.00
CHR.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 13255850.00
CHR.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 13255850.00
CHR.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
CHR.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
CHR.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
CHR.AX balance_sheet (annual, 2024-06-30) — Total Assets: 13740392.00
CHR.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 13255850.00
CHR.AX balance_sheet (annual, 2024-06-30) — Total Debt: 89404.00
CHR.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 13255850.00
CHR.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 484542.00
CHR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 10396985.00
CHR.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 47428.00
CHR.AX income_statement (annual, 2024-06-30) — Total Unusual Items: -279940.00
CHR.AX income_statement (annual, 2024-06-30) — Total Unusual Items Excluding Goodwill: -279940.00
CHR.AX balance_sheet (annual, 2024-06-30) — Working Capital: 2906293.00
CHR.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 93918702.00
CHR.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.02
CHR.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 93918702.00
CHR.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.02
CHR.AX income_statement (annual, 2025-06-30) — General And Administrative Expense: 892237.00
CHR.AX income_statement (annual, 2025-06-30) — Other Gand A: 441782.00
CHR.AX income_statement (annual, 2025-06-30) — Other Operating Expenses: 1462185.00
CHR.AX income_statement (annual, 2025-06-30) — Selling General And Administration: 892237.00
CHR.DE cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
CHR.DE balance_sheet (annual, 2021-12-31) — Income Tax Payable: 900000.00
CHR.DE balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 663600000.00
CHR.DE income_statement (annual, 2021-12-31) — Net Income Discontinuous Operations: 0.00
CHR.DE cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: 0.00
CHR.DE balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 39900000.00
CHR.DE cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 0.00
CHR.DE cash_flow (annual, 2021-12-31) — Sale Of Business: 0.00
CHR.DE cash_flow (annual, 2021-12-31) — Sale Of PPE: 0.00
CHR.DE balance_sheet (annual, 2021-12-31) — Total Tax Payable: 900000.00
CHR.DE income_statement (annual, 2022-12-31) — +Operating Expense: 164200000.00
CHR.DE income_statement (annual, 2022-12-31) — +Total Revenue: 1809800000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 145500000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 12500000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -837100000.00
CHR.DE cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 38300000.00
CHR.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 75800000.00
CHR.DE income_statement (annual, 2022-12-31) — Basic EPS: 5.79
CHR.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 355600000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 1217800000.00
CHR.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -456800000.00
CHR.DE cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -423500000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 0.00
CHR.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 129800000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 129800000.00
CHR.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -26000000.00
CHR.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 2416000000.00
CHR.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -3103700000.00
CHR.DE cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 510800000.00
CHR.DE cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 26000000.00
CHR.DE cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 36600000.00
CHR.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: 36600000.00
CHR.DE cash_flow (annual, 2022-12-31) — Changes In Cash: -150900000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Common Stock: 0.00
CHR.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 551500000.00
CHR.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: -174900000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Construction In Progress: 353700000.00
CHR.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 1243400000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 153200000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Current Assets: 344500000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Current Debt: 47000000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 47000000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 89600000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 39000000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 621600000.00
CHR.DE cash_flow (annual, 2022-12-31) — Deferred Income Tax: 108700000.00
CHR.DE cash_flow (annual, 2022-12-31) — Deferred Tax: 108700000.00
CHR.DE cash_flow (annual, 2022-12-31) — Depreciation: 119000000.00
CHR.DE cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 119000000.00
CHR.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 119000000.00
CHR.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 77000000.00
CHR.DE income_statement (annual, 2022-12-31) — Diluted EPS: 5.71
CHR.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 439400000.00
CHR.DE cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 156900000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Dividends Payable: 27000000.00
CHR.DE income_statement (annual, 2022-12-31) — EBIT: 756100000.00
CHR.DE income_statement (annual, 2022-12-31) — EBITDA: 875100000.00
CHR.DE income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 152700000.00
CHR.DE cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -152700000.00
CHR.DE cash_flow (annual, 2022-12-31) — End Cash Position: 204700000.00
CHR.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: 2416000000.00
CHR.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 80000000.00
CHR.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -274600000.00
CHR.DE income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 274600000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -900000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Goodwill: 723800000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 3115600000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 2815400000.00
CHR.DE income_statement (annual, 2022-12-31) — Gross Profit: 566400000.00
CHR.DE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 38300000.00
CHR.DE cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 68600000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Income Tax Payable: 2100000.00
CHR.DE income_statement (annual, 2022-12-31) — Interest Expense: 147300000.00
CHR.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 147300000.00
CHR.DE cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 133600000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Interest Payable: 47800000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 5157200000.00
CHR.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -3103700000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Investments And Advances: 659400000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 659400000.00
CHR.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2862400000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Land And Improvements: 161200000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 4558700000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4558700000.00
CHR.DE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2862400000.00
CHR.DE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -205400000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 659400000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 172000000.00
CHR.DE income_statement (annual, 2022-12-31) — Minority Interests: 0.00
CHR.DE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -2918500000.00
CHR.DE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -174900000.00
CHR.DE balance_sheet (annual, 2022-12-31) — Net Debt: 4475900000.00
CHR.DE income_statement (annual, 2022-12-31) — Net Income: 439400000.00
CHR.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 439400000.00
CHR.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 439400000.00
CHR.DE income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CHR.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 439400000.00
CHR.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 439400000.00
CHR.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 439400000.00
CHR.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 439400000.00
CHR.DE cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -33300000.00
CHR.DE income_statement (annual, 2022-12-31) — Net Interest Income: -147300000.00